The Merck Manual, 11th Ed., pp. 1055-1059 (1966). |
Aumailley et al., FEBS, vol. 291, No. 1, pp. 50-54, (Oct. 1991). |
Smith et al., Journal of Biological Chemistry., vol. 265, No. 21, pp. 12267-12271 (1990). |
Gerhard Muller et al. "Dynamic Forcing a Method of Evaluating Activity and Selectivity Profiles of RGD (Arg-Gly-Asp) Peptides," Angewandte Chemie, International Edition, vol. 31, No. 3, Mar. 1992, pp. 326-328. |
Stanley E. D'Souza et al., "Arginyl-glycyl-aspartic acid (RGD): A Cell Adhesion Motif" Trends in Biochemical Sciences, vol. 16, No. 7, Jul. 1991, pp. 246-250. |
"Requirment of Vascular Integrin .alpha..sub.v .beta..sub.3 for Angiogenesis", Brooks et al., Science, 264:569-571, Apr. 1994. |
"Angiogenesis Inhibitors from Scripps and Ixsys Shrink Tumors", Genetic Technology News, pp. 6-7, Feb. 1995. |
"Scripps Research Scientists Develop New Technique for Treating Malignant Tumors", Genetic Engineering News, 15(2):1, Jan. 1995. |
"Integrin .alpha..sub.v .beta..sub.3 Antagonists Promote Regression by Inducing . . . ", Brooks et al., Cell, 79:1157-1164, Dec. 1994. |